Immutep
As of the edition of 20 October 2026, Immutep runs 3 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 3 company names in this family.
- Prima BioMed Ltd: acquired in 2017; successor Immutep Limited
Drugs by status
| Status | Count |
|---|---|
| Active | 3 |
| Total | 3 |
Where its trials are
- Cancer: 7 trials led
- Skin and connective tissue: 3 trials led
- Lungs and airways: 1 trials led